IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding IO Biotech, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 20 | 19 | −1 |
| Shares | 15.0M | 14.9M | −179.6K (−1.2%) |
| Value | $92.6M | $76.9M | −$15.7M (−17.0%) |
New holders (4)
Institutions that held IO Biotech, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 26,676 | $141.0K | 0.00% |
| Jane Street Group, LLC | 14,280 | $76.0K | 0.00% |
| Ergoteles LLC | 11,126 | $59.0K | 0.00% |
| Citigroup Inc | 164 | $1.00K | 0.00% |
Sold out (5)
Institutions that held IO Biotech, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Caas Capital Management LP | 50,479 | $323.0K |
| Squarepoint Ops LLC | 14,966 | $98.0K |
| Citadel Advisors LLC | 13,060 | $86.0K |
| Virtu Financial LLC | 12,665 | $83.0K |
| Tower Research Capital LLC (TRC) | 1,572 | $10.0K |